Company: UHS
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0000950170-25-049925
Chunk: 65

Company: UNIVERSAL HEALTH SERVICES INC
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 65
---
 |   |     |          |        |     |            |     |                   |      — |     |            |            — |     |           |  5,948 |     |              | 1,067,190 |
|                     |     |                    |       — |     |               |  8,425 |     |             | — |     | $        | 138.80 |     | 03/16/2026 |     |                   |      — |     |            |            — |     |           |      — |     |              |         — |
|                     |     |                    |       — |     |               |  9,465 |     |             | — |     | $        | 152.68 |     | 03/16/2026 |     |                   |      — |     |            |            — |     |           |      — |     |              |         — |
| ﻿                   |     |                    |       — |     |               | 10,872 |     |             | — |     | $        | 143.81 |     | 03/22/2027 |     |                   |      — |     |            |            — |     |           |      — |     |              |         — |

Stock option awards . All stock options are scheduled to vest ratably on the first, second, third and fourth anniversary dates from the date of grant.

The applicable grant dates for the options indicated above are set forth below:

On March 18, 2020, stock options were granted with an exercise price of $67.69.

On March 18, 2020, stock premium stock options were granted with a 10% premium exercise price of $74.46.

On March 17, 2021, stock options were granted with an exercise price of $138.80.

On March 17, 2021, stock premium stock options were granted with a 10% premium exercise price of $152.68.

On March 23, 2022, stock options were granted with an exercise price of $143.81.

On January 18, 2023, stock options were granted with an exercise price of $145.65

On March 15, 2023, stock options were granted with an exercise price of $117.65.

Performance-Based Restricted Stock Units . On March 21, 2024, 100% of the annual target stock-based